Back to Results
First PageMeta Content
Glycoproteins / Medicine / Biotechnology / Monoclonal antibodies / Monoclonal antibody therapy / Antibody / Polyclonal antibodies / Immunoglobulin G / Symphogen / Biology / Immunology / Immune system


factsheet_company_2012_04web
Add to Reading List

Document Date: 2012-09-24 10:16:16

Open Document

File Size: 1,13 MB

Share Result on Facebook

Company

IgG / Venture Investments Life Sciences Partners / Company Overview Merus / Novartis Pharma / Merus B.V. / /

Currency

EUR / /

/

Event

Funding / Business Partnership / /

Facility

Pipeline Merus / /

IndustryTerm

mouse technology / clonal manufacturing cell lines / diversiļ¬ed immunoglobulin heavy chains / biotechnology / cancer therapy / dimerization technology / manufacturing cell line / antibody light chain / heavy chains / clonal manufacturing cell line using standard approaches / light chain / dimerization technologies / /

MedicalCondition

thereby eliminating tumor / tumor / cancer / solid tumors / /

MedicalTreatment

immunization / cancer therapy / /

Person

Lionel Carnot Wolf Berthold / Mark Krul Gabriele Dallmann Elaine / Gerard van Odijk / Mark Throsby / Jason Avery / Shelley Margetson / John de Kruif / Lex Bakker / /

Position

CEO / Chairman / COO / CFO / /

Technology

antibodies / biotechnology / treating cancer / CH3 dimerization technologies / Florent Gros Lionel Carnot Wolf Berthold John de Koning Mark Krul Gabriele Dallmann Elaine Jones Technology / mouse technology / CH3 dimerization technology / /

URL

www.merus.nl / /

SocialTag